The amendment, sponsored by Sen. Byron Dorgan, D-N.D., and Sen. Olympia Snowe, R-Maine, would have permitted U.S. consumers to purchase FDA-approved drugs from other nations that meet certain drug-safety standards. Supporters said such a measure could save Americans $80 billion over 10 years, The Washington Independent reported Tuesday.
However, the amendment was opposed by the pharmaceutical industry, which has said it would commit to about $80 billion in savings for consumers over 10 years. The Senate voted 51-48 on a measure to end a filibuster on the amendment, effectively killing it.
Thirty Democrats and one Independent, Joe Lieberman of Connecticut, voted against the re-importation amendment.
The White House had urged Democrats to oppose the amendment, the newspaper said.
Republicans John McCain of Arizona and Charles Grassley of Iowa were among those supporting re-importation.
The Senate also voted Tuesday to kill a watered-down version of the amendment, the Independent reported.